F
Fabrizio Carinci
Researcher at University of Bologna
Publications - 62
Citations - 1347
Fabrizio Carinci is an academic researcher from University of Bologna. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 21, co-authored 51 publications receiving 1118 citations. Previous affiliations of Fabrizio Carinci include University of Perugia & Mario Negri Institute for Pharmacological Research.
Papers
More filters
Journal ArticleDOI
Towards actionable international comparisons of health system performance: expert revision of the OECD framework and quality indicators
Fabrizio Carinci,K. Van Gool,Jan Mainz,Jeremy Veillard,E. C. Pichora,Jean-Marie Januel,I. Arispe,S. M. Kim,Nicolaas S. Klazinga +8 more
TL;DR: The revised OECD framework for HCQI represents a new milestone of a long-standing international collaboration among a group of countries committed to building common ground for performance measurement.
Journal ArticleDOI
A Comprehensive Assessment of the Avoidability of Long-Term Complications of Diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
Antonio Nicolucci,D. Cavaliere,N. Scorpiglione,Fabrizio Carinci,Fabio Capani,Gianni Tognoni,M. Massi Benedetti +6 more
TL;DR: The data suggest that the number of diabetic complications considered could be reduced by more than one-third by removing avoidable risk factors, with particular emphasis on those variables that, being related to quality of care, can be considered avoidable.
Journal ArticleDOI
Covid-19: preparedness, decentralisation, and the hunt for patient zero.
TL;DR: Lessons from the Italian outbreak as mentioned in this paper, which is the origin of the current outbreak, are discussed in Section 5.1.1] and Section 6.2.1.
Journal ArticleDOI
A Meta‐analysis of Trials on Aldose Reductase Inhibitors in Diabetic Peripheral Neuropathy
Antonio Nicolucci,Fabrizio Carinci,D. Cavaliere,N. Scorpiglione,Maurizio Belfiglio,D Labbrozzi,E. Mari,M. Massi Benedetti,Gianni Tognoni,A. Liberati +9 more
TL;DR: Although the results of 1‐year treatment on motor NCV seem encouraging, the uncertainty about the reliability of the end‐point employed and the short treatment duration do not allow any clear conclusion about the efficacy of ARIs in the treatment of peripheral diabetic neuropathy.
Journal ArticleDOI
Lower extremity amputation rates in people with diabetes as an indicator of health systems performance. A critical appraisal of the data collection 2000–2011 by the Organization for Economic Cooperation and Development (OECD)
TL;DR: In OECD countries, amputation rates in diabetes continuously decreased over 12 years, and in 2011, one amputation every 7 min could be directly attributed to diabetes.